<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://wiki.go-eqipd.org/index.php?action=history&amp;feed=atom&amp;title=EQIPD%3AAbout</id>
	<title>EQIPD:About - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://wiki.go-eqipd.org/index.php?action=history&amp;feed=atom&amp;title=EQIPD%3AAbout"/>
	<link rel="alternate" type="text/html" href="https://wiki.go-eqipd.org/index.php?title=EQIPD:About&amp;action=history"/>
	<updated>2026-05-13T00:03:07Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.31.0</generator>
	<entry>
		<id>https://wiki.go-eqipd.org/index.php?title=EQIPD:About&amp;diff=18864&amp;oldid=prev</id>
		<title>Antonbespalov: Created page with &quot;To support robustness and reliability of preclinical biomedical research in a collaborative manner, the Enhancing Quality in Preclinical Data (EQIPD; originally called Europea...&quot;</title>
		<link rel="alternate" type="text/html" href="https://wiki.go-eqipd.org/index.php?title=EQIPD:About&amp;diff=18864&amp;oldid=prev"/>
		<updated>2021-07-15T09:18:15Z</updated>

		<summary type="html">&lt;p&gt;Created page with &amp;quot;To support robustness and reliability of preclinical biomedical research in a collaborative manner, the Enhancing Quality in Preclinical Data (EQIPD; originally called Europea...&amp;quot;&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;To support robustness and reliability of preclinical biomedical research in a collaborative manner, the Enhancing Quality in Preclinical Data (EQIPD; originally called European Quality in Preclinical Data) consortium was formed in 2017 with founding members from 29 institutions across 8 different countries. The consortium works closely with a large group of associated collaborators, advisors and stakeholders representing research institutions, publishers, funders, learned societies and professional societies, from nearly 110 organizations in Europe and North America.&lt;br /&gt;
&lt;br /&gt;
This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 777364. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.&lt;/div&gt;</summary>
		<author><name>Antonbespalov</name></author>
		
	</entry>
</feed>